Literature DB >> 14580891

Displaying and epitope mapping of CD147 on VCSM13 phages: influence of Escherichia coli strains.

Chatchai Tayapiwatana1, Pramoon Arooncharus, Watchara Kasinrerk.   

Abstract

The external domain of a human leukocyte surface molecule, CD147 was displayed on the surface of phage. Two Escherichia coli laboratory strains, XL-1 Blue and TG-1, were chosen to separately propagate the recombinant phages. By sandwich enzyme linked immunosorbent assay (ELISA), CD147 on phage particles were individually captured by six CD147 mAbs and subsequently detected by anti-M13 conjugated HRP. All mAbs specifically bound the CD147 on phage particles derived from TG-1. On the contrary, only four of them could recognize the CD147 on phages produced by XL-1 Blue. The results indicate that the environment in the TG-1 periplasm is more appropriate than that of XL-1 Blue for promoting the suitable folding of CD147. This finding emphasizes the importance of selecting the appropriate E. coli host for display of a complex protein. The epitopes of CD147 displayed on the phage were further mapped by competitive inhibition ELISA, which is a reliable and economical method. Certain clusters of mAb recognition areas were identified and will provide valuable information for the discovery of the ligand for CD147.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580891     DOI: 10.1016/s0022-1759(03)00270-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Blockade of CD28 by a synthetical peptoid inhibits T-cell proliferation and attenuates graft-versus-host disease.

Authors:  Na Li; Faliang Zhu; Fei Gao; Qun Wang; Xiaoyan Wang; Haiyan Li; Chunhong Ma; Wensheng Sun; Wenfang Xu; Chaodong Wang; Lining Zhang
Journal:  Cell Mol Immunol       Date:  2010-02-08       Impact factor: 11.530

2.  Immunoreactivity of humanized single-chain variable fragment against its functional epitope on domain 1 of CD147.

Authors:  Nutjeera Intasai; Kuntalee Rangnoi; Montarop Yamabhai; Thanathat Pamonsupornwichit; Weeraya Thongkum; Umpa Yasamut; Koollawat Chupradit; Nuchjira Takheaw; Piyarat Nimmanpipug; Chatchai Tayapiwatana
Journal:  Sci Rep       Date:  2022-04-25       Impact factor: 4.996

3.  When recombinant proteins can replace rare red cells in immunohematology workups.

Authors:  Willy A Flegel; Kshitij Srivastava
Journal:  Transfusion       Date:  2021-05-31       Impact factor: 3.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.